Aspirin therapy
This article was originally published in The Tan Sheet
Executive Summary
Daily doses of 75 mg-150 mg per day reduce risk of vascular events by 32% in high-risk patients, according to meta-analysis by Antithrombotic Trialists' Collaboration (Oxford, England) in Jan. 12 British Medical Journal. C. Baigent, et al., reviewed a total of 287 studies involving 212,000 patients that compared antiplatelet therapy with either controls or other antiplatelet regimens. Accompanying editorial by John Cleland, University of Hull, maintains aspirin efficacy is overstated since it does not reduce mortality...